These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6737232)

  • 1. Urinary excretion of chlorpheniramine and its metabolites in children.
    Simons KJ; Simons FE; Luciuk GH; Frith EM
    J Pharm Sci; 1984 May; 73(5):595-9. PubMed ID: 6737232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary excretion of chlorpheniramine and pseudoephedrine in humans.
    Lai CM; Stoll RG; Look ZM; Yacobi A
    J Pharm Sci; 1979 Oct; 68(10):1243-6. PubMed ID: 41928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of the enantiomers of chlorpheniramine and its main monodesmethyl metabolite in urine using achiral-chiral liquid chromatography.
    Hiep BT; Khanh V; Hung NK; Thuillier A; Gimenez F
    J Chromatogr B Biomed Sci Appl; 1998 Apr; 707(1-2):235-40. PubMed ID: 9613955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical pharmacokinetics of chlorpheniramine.
    Rumore MM
    Drug Intell Clin Pharm; 1984 Sep; 18(9):701-7. PubMed ID: 6383755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and efficacy of chlorpheniramine in children.
    Simons FE; Luciuk GH; Simons KJ
    J Allergy Clin Immunol; 1982 Apr; 69(4):376-81. PubMed ID: 7069073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chlorpheniramine. I. Rapid quantitative analysis of chlorpheniramine in plasma, saliva and urine by high-performance liquid chromatography.
    Athanikar NK; Peng GW; Nation RL; Huang SM; Chiou WL
    J Chromatogr; 1979 Mar; 162(3):367-76. PubMed ID: 528601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of intravenous chlorpheniramine in children.
    Thompson JA; Bloedow DC; Leffert FH
    J Pharm Sci; 1981 Nov; 70(11):1284-6. PubMed ID: 7299679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chlorpheniramine dissolution and relative urinary excretion from commercial products.
    Hsu HY; Ayres JW
    J Pharm Sci; 1989 Oct; 78(10):844-7. PubMed ID: 2600791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation and identification of the polar metabolites of chlorpheniramine in the dog.
    Osterloh JD; Karakaya A; Carter DE
    Drug Metab Dispos; 1980; 8(1):12-5. PubMed ID: 6102024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. INFLUENCE OF URINE PH AND FLOW RATE ON THE RENAL EXCRETION OF CHLORPHENIRAMINE IN MAN.
    BECKETT AH; WILKINSON GR
    J Pharm Pharmacol; 1965 Apr; 17():256-7. PubMed ID: 14327721
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacokinetics of sulphamethoxazole in man: effects of urinary pH and urine flow on metabolism and renal excretion of sulphamethoxazole and its metabolite N4-acetylsulphamethoxazole.
    Vree TB; Hekster YA; Baars AM; Damsma JE; van der Kleijn E
    Clin Pharmacokinet; 1978; 3(4):319-29. PubMed ID: 28128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical pharmacokinetics of H1-receptor antagonists (the antihistamines).
    Paton DM; Webster DR
    Clin Pharmacokinet; 1985; 10(6):477-97. PubMed ID: 2866055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skin permeation of chlorpheniramine maleate and detection of demethylated metabolites by high-performance liquid chromatography.
    Zbaida S; Touitou E
    J Pharm Sci; 1988 Feb; 77(2):188-90. PubMed ID: 3361436
    [No Abstract]   [Full Text] [Related]  

  • 14. Liquid chromatography-tandem mass spectrometry method for the simultaneous analysis of multiple hallucinogens, chlorpheniramine, ketamine, ritalinic acid, and metabolites, in urine.
    del Mar Ramirez Fernandez M; Laloup M; Wood M; De Boeck G; Lopez-Rivadulla M; Wallemacq P; Samyn N
    J Anal Toxicol; 2007 Oct; 31(8):497-504. PubMed ID: 17988464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The optical resolution of racemic chlorpheniramine and its stereoselective pharmacokinetics in rat plasma.
    Sakurai E; Yamasaki S; Iizuka Y; Hikichi N; Niwa H
    J Pharm Pharmacol; 1992 Jan; 44(1):44-7. PubMed ID: 1350627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous GLC determination of phenylpropanolamine and chlorpheniramine in urine using a nitrogen selective detector.
    Kinsun H; Moulin MA; Savini EC
    J Pharm Sci; 1978 Jan; 67(1):118-9. PubMed ID: 619099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Steady-state pharmacokinetics of metronidazole in Crohn's disease.
    Eradiri O; Jamali F; Thomson AB
    Biopharm Drug Dispos; 1987; 8(3):249-59. PubMed ID: 3593902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary excretion kinetics of pyrene and benzo(a)pyrene metabolites following intravenous administration of the parent compounds or the metabolites.
    Bouchard M; Viau C
    Toxicol Appl Pharmacol; 1996 Aug; 139(2):301-9. PubMed ID: 8806846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of single doses of sulphinpyrazone and its major metabolites in plasma and urine.
    Bradbrook ID; John VA; Morrison PJ; Rogers HJ; Spector RG
    Br J Clin Pharmacol; 1982 Feb; 13(2):177-85. PubMed ID: 7059415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of morphine and its surrogates. VII: High-performance liquid chromatographic analyses and pharmacokinetics of methadone and its derived metabolites in dogs.
    Garrett ER; Derendorf H; Mattha AG
    J Pharm Sci; 1985 Nov; 74(11):1203-14. PubMed ID: 4087182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.